BRPI0603759A - associação entre agomelatina e um inibidor de recaptação de noradrenalina, e composições farmacêuticas contendo-a - Google Patents

associação entre agomelatina e um inibidor de recaptação de noradrenalina, e composições farmacêuticas contendo-a

Info

Publication number
BRPI0603759A
BRPI0603759A BRPI0603759-3A BRPI0603759A BRPI0603759A BR PI0603759 A BRPI0603759 A BR PI0603759A BR PI0603759 A BRPI0603759 A BR PI0603759A BR PI0603759 A BRPI0603759 A BR PI0603759A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
compositions containing
agomelatine
norepinephrine reuptake
reuptake inhibitor
Prior art date
Application number
BRPI0603759-3A
Other languages
English (en)
Inventor
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0603759A publication Critical patent/BRPI0603759A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ASSOCIAçãO ENTRE AGOMELATINA E UM INIBIDOR DE RECAPTAçãO DE NORADRENALINA, E COMPOSIçõES FARMACêUTICAS CONTENDO-A. A presente invenção refere-se a uma associação compreendendo agomelatina, ou N-{2-(7-metóxi-1-naftil)etil}acetamina, associada a um agente inibidor de recaptação de noradrenalina.
BRPI0603759-3A 2005-09-09 2006-09-06 associação entre agomelatina e um inibidor de recaptação de noradrenalina, e composições farmacêuticas contendo-a BRPI0603759A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
BRPI0603759A true BRPI0603759A (pt) 2007-05-15

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0603759-3A BRPI0603759A (pt) 2005-09-09 2006-09-06 associação entre agomelatina e um inibidor de recaptação de noradrenalina, e composições farmacêuticas contendo-a

Country Status (40)

Country Link
US (1) US7622505B2 (pt)
EP (1) EP1769798B1 (pt)
JP (2) JP5395998B2 (pt)
KR (1) KR100863384B1 (pt)
CN (1) CN1927205A (pt)
AP (1) AP2615A (pt)
AR (1) AR056056A1 (pt)
AT (1) ATE404205T1 (pt)
AU (1) AU2006209368B2 (pt)
BR (1) BRPI0603759A (pt)
CA (1) CA2558782C (pt)
CY (1) CY1108319T1 (pt)
DE (1) DE602006002210D1 (pt)
DK (1) DK1769798T3 (pt)
EA (1) EA011650B1 (pt)
ES (1) ES2313590T3 (pt)
FR (1) FR2890564B1 (pt)
GE (1) GEP20094742B (pt)
GT (1) GT200600408A (pt)
HR (1) HRP20080535T3 (pt)
JO (1) JO2521B1 (pt)
MA (1) MA28505B1 (pt)
ME (2) ME02758B (pt)
MX (1) MXPA06010157A (pt)
MY (1) MY142260A (pt)
NO (1) NO338029B1 (pt)
NZ (1) NZ549725A (pt)
PE (1) PE20070429A1 (pt)
PL (1) PL1769798T3 (pt)
PT (1) PT1769798E (pt)
PY (1) PY0626552A (pt)
RS (1) RS50631B (pt)
SA (1) SA06270308B1 (pt)
SG (1) SG131030A1 (pt)
SI (1) SI1769798T1 (pt)
TW (1) TWI324513B (pt)
UA (1) UA83542C2 (pt)
UY (1) UY29778A1 (pt)
WO (1) WO2007028904A1 (pt)
ZA (1) ZA200607562B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008137461A1 (en) * 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl) acetamides
WO2008141033A1 (en) * 2007-05-08 2008-11-20 Auspex Pharmaceuticals Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
AU9692898A (en) * 1997-10-17 1999-05-10 Eli Lilly And Company Potentiation of pharmaceuticals
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
WO2003072138A1 (en) * 2002-02-26 2003-09-04 Ortho-Mcneil Pharmaceutical Inc. Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
AU2004271796A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Combination comprising an alpha-2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders

Also Published As

Publication number Publication date
PE20070429A1 (es) 2007-06-02
JP2007077147A (ja) 2007-03-29
SG131030A1 (en) 2007-04-26
JP2011088919A (ja) 2011-05-06
DE602006002210D1 (de) 2008-09-25
GT200600408A (es) 2007-05-21
AU2006209368A1 (en) 2007-03-29
EA011650B1 (ru) 2009-04-28
ME02758B (me) 2010-06-30
EP1769798B1 (fr) 2008-08-13
ZA200607562B (en) 2008-05-28
MXPA06010157A (es) 2007-03-08
KR100863384B1 (ko) 2008-10-13
US7622505B2 (en) 2009-11-24
ME02767B (me) 2010-06-30
MY142260A (en) 2010-11-15
EP1769798A1 (fr) 2007-04-04
UY29778A1 (es) 2006-10-31
CA2558782A1 (fr) 2007-03-09
FR2890564B1 (fr) 2007-10-19
CN1927205A (zh) 2007-03-14
SI1769798T1 (sl) 2008-12-31
NZ549725A (en) 2008-03-28
AU2006209368B2 (en) 2012-07-19
AR056056A1 (es) 2007-09-12
JP5395998B2 (ja) 2014-01-22
MA28505B1 (fr) 2007-04-03
EA200601410A1 (ru) 2007-04-27
ATE404205T1 (de) 2008-08-15
WO2007028904A1 (fr) 2007-03-15
PY0626552A (es) 2011-01-03
UA83542C2 (uk) 2008-07-25
FR2890564A1 (fr) 2007-03-16
US20070060654A1 (en) 2007-03-15
GEP20094742B (en) 2009-07-27
ES2313590T3 (es) 2009-03-01
NO338029B1 (no) 2016-07-25
PT1769798E (pt) 2008-09-18
TWI324513B (en) 2010-05-11
SA06270308B1 (ar) 2011-10-08
PL1769798T3 (pl) 2008-12-31
CA2558782C (fr) 2012-05-15
CY1108319T1 (el) 2014-02-12
AP2008004378A0 (en) 2008-04-30
DK1769798T3 (da) 2008-11-24
KR20070029606A (ko) 2007-03-14
TW200744570A (en) 2007-12-16
NO20064048L (no) 2007-03-12
JO2521B1 (en) 2010-03-17
AP2615A (en) 2013-03-14
HRP20080535T3 (en) 2008-12-31
RS50631B (sr) 2010-06-30

Similar Documents

Publication Publication Date Title
CY1122861T1 (el) Φαρμακευτικες συνθεσεις της αμορφης μορφης ν-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδιου
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
DK2101569T3 (da) Krystallinsk fast rasagilinbase
BRPI0714558B8 (pt) processo para a preparação de (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol
NO20074807L (no) Fast farmasoytisk doseringsformulering
BR0316535A (pt) Composição farmacêutica de um agonista adrenoceptor beta-3 e um inibidor de reuptake de serotonina e/ou norepinefrina
CY1118976T1 (el) Κρυσταλλικες τροποποιησεις της (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολης
BRPI0606118A2 (pt) uma sìntese assimétrica de (s) - (+) -3- (aminometil) -5- ácido metilhexanóico
BR0300119A (pt) Composição aquosa, e, estrutura compósita
BRPI0512820A (pt) composição de matéria, e método de revestir um metal
AR047553A1 (es) La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
WO2007120725A3 (en) Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
PA8571901A1 (es) Nueva composicion farmaceutica
SG143203A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome
BRPI0603759A (pt) associação entre agomelatina e um inibidor de recaptação de noradrenalina, e composições farmacêuticas contendo-a
NO20032494L (no) Farmasoytisk blanding
UY29400A1 (es) Base libre de lercanidipina.
BRPI0603767A (pt) associação entre agomelatina e um agente timorregulador, e composições contendo a mesma
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent
BRPI0502164A (pt) Composição cosmética à base de bromelina
BRPI0501052A (pt) composição cosmética à base de papaìna
UY27785A1 (es) Nueva composición farmacéutica
TW200744571A (en) Combination of β3 receptor agonist and of monoamine reuptake inhibitors, pharmaceutical composition containing it and therapeutic use thereof
BRPI0401464A (pt) Composições farmacêuticas e/ou cosméticas apresentando propriedades rejuvenescedoras
BRPI0500370A (pt) Mono estearato de glicerila

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements